Behrang Kianzad
Ekstern forsker, Guest Researcher
JUR Center for Advanced Studies in Bioscience Innovation Law
Karen Blixens Plads 16
2300 København S
Member of:
- 2018
- Published
How much is too much?- Defining the Metes and Bounds of Excessive Pricing in the Pharmaceutical Sector
Kianzad, Behrang & Minssen, Timo, 2018, In: European Pharmaceutical Law Review. 2, 3, p. 133-148 16 p.Research output: Contribution to journal › Journal article › Research › peer-review
- 2019
- Published
Excessive Pharmaceutical Prices as an Anticompetitive Practice in TRIPS and European Competition Law
Kianzad, Behrang, 15 Mar 2019, New Developments in Competition Law and Economics. Mathis, K. & Tor, A. (eds.). Springer, p. 197-220 24 p.Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review
- Published
Würtz v. Coop - Decision of the Danish Supreme Court 18 December 2018 – Case No. 171/2017
Kianzad, Behrang (Translator), 25 Nov 2019, In: I I C - International Review of Intellectual Property and Competition Law. p. 109-112 4 p.Research output: Contribution to journal › Journal article › Commissioned › peer-review
- 2020
- Published
Konkurrensrättsliga aspekter av Corona-krisen
Kianzad, Behrang, 2020, Dagens Juridik.Research output: Other contribution › Research
- Published
De minimis exception when using applied art in marketing materials
Kianzad, Behrang, 1 Jan 2020, In: GRUR International. 69, 1, p. 91-105 15 p.Research output: Contribution to journal › Journal article › Commissioned › peer-review
- Published
SWEDEN’s Response to COVID-19: A tale of trust, recommendations, and odorous nudges: Available at: https://blog.petrieflom.law.harvard.edu/2020/05/12/sweden-global-responses-covid19/
Kianzad, Behrang & Minssen, Timo, May 2020, Harvard Law School's Bill of Health blog.Research output: Other contribution › Net publication - Internet publication › Research › peer-review
- Published
Legal Remedies In Times of Global Pandemic Crisis-Price Gouging, Compulsory Licensing and the role of Antitrust
Kianzad, Behrang & Minssen, Timo, 23 Oct 2020.Research output: Contribution to conference › Paper › Research
- Published
Did the Danish Supreme Court Give the Fashion Industry the Kantian Boot?
Kianzad, Behrang, 9 Dec 2020, In: GRUR International. 70, 2, p. 159-163 5 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
No Copyright Protection for a Footwear Design
Kianzad, Behrang (Translator), 22 Dec 2020, In: GRUR International. 70, 2, p. 200-204 5 p.Research output: Contribution to journal › Journal article › Commissioned › peer-review
- 2021
- Published
Compulsory Licensing
Kianzad, Behrang, 2021, Encyclopedia of Law and Economics. Marciano, A. & Ramello, G. B. (eds.). New York, NY: Springer New YorkResearch output: Chapter in Book/Report/Conference proceeding › Encyclopedia chapter › Research › peer-review
- Published
Excessive Pharmaceutical Pricing as an Abuse of Dominant Position – The Case of CD Pharma (Denmark)
Kianzad, Behrang, 2021, In: GRUR International. 70, 12, p. 1188-1196 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Excessive Pricing
Kianzad, Behrang, 2021, Encyclopedia of Law and Economics. Marciano, A. & Ramello, G. B. (eds.). New York, NY: Springer New YorkResearch output: Chapter in Book/Report/Conference proceeding › Encyclopedia chapter › Research › peer-review
- Published
Excessive Pricing during COVID-19 crisis in the EU: An Empirical Inquiry
Kianzad, Behrang, 2021, In: Concurrences. 2021, 1, p. 250-259 10 p., 98670.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The Giant Awakens - Law and Economics of Excessive Pricing & COVID-19 Crisis
Kianzad, Behrang, 2021.Research output: Contribution to conference › Paper › Research
- Published
‘No-one is Safe Until Everyone is Safe’ – Patent Waiver, Compulsory Licensing and COVID-19
Kianzad, Behrang & Wested, Jakob, 2021, In: European Pharmaceutical Law Review. 5, 2, p. 71-91 21 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Let´s Dance! Excessive Royalties and the Economic Value of Music (C-372/19 SABAM)
Kianzad, Behrang, 11 Jun 2021, In: European Competition and Regulatory Law Review. 5, 2, p. 172-176 5 p.Research output: Contribution to journal › Journal article › Research › peer-review
- 2022
- Published
"Compulsory Licensing" in Global Dictionary of Competition Law, Concurrences
Kianzad, Behrang, 2022, Concurrences. Concurrences, Vol. Art. N° 86433.Research output: Chapter in Book/Report/Conference proceeding › Encyclopedia chapter › Research › peer-review
- Published
Temporary Dominance and Excessive Pharmaceutical Pricing – CD Pharma (Denmark)
Kianzad, Behrang, 2022, EU Competition Law and Pharmaceuticals . Sauter, W., Canoy, M. & Mulder, J. (eds.). Edward Elgar Publishing, p. 124–137 (New Horizons in Competition Law and Economics series).Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review
- Published
The Giant Awakens: Law and Economics of Excessive Pricing during COVID-19 Crisis
Kianzad, Behrang, 2022, Law and Economics of the Coronavirus Crisis: New Developments in Competition Law and Economics. Mathis, K. & Tor, A. (eds.). Springer, p. 123–176 (Economic Analysis of Law in European Legal Scholarship; No. 13).Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review
- Published
The Limits of Control: Competition Law Versus Sector Regulation in the Wake of the European Commission Excessive Pricing Decision in Aspen
Kianzad, Behrang, 2022, In: European Competition and Regulatory Law Review. 6, 3, p. 207 - 221 14 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Towards Fair Pricing of Medicines? Lessons from the European Commission's Aspen Decision
Kianzad, Behrang, 2022, In: European Pharmaceutical Law Review. 6, 1, p. 3 - 23 21 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
What Makes A Price (Un)Fair? Excessive Pharmaceutical Pricing in European Competition Law
Kianzad, Behrang, 26 Jul 2022, København: Det Juridiske Fakultet. 564 p.Research output: Book/Report › Ph.D. thesis › Research
ID: 182567918
Most downloads
-
68
downloads
Legal Remedies In Times of Global Pandemic Crisis-Price Gouging, Compulsory Licensing and the role of Antitrust
Research output: Contribution to conference › Paper › Research
Published -
32
downloads
‘No-one is Safe Until Everyone is Safe’ – Patent Waiver, Compulsory Licensing and COVID-19
Research output: Contribution to journal › Journal article › Research › peer-review
Published